Letter to stakeholders regarding the implementation of safety features under the Falsified Medicines Directive 2011/62/EU

The delegated Regulation on the characteristics of the safety features and the new medicine verification system will apply as of 9 February 2019. More information for marketing authorisation holders, wholesalers or pharmacies is available in the joint letter drafted by DG Santé, HMA and EMA.